XML 14 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statement of Stockholders' Deficiency - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2016
Preferred Stock Series E [Member]      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning    
Capital Contribution from Reverse Merger     $ 29
Capital Contribution from Reverse Merger (in shares)     28,500
Balance at ending   $ 29 $ 29
Balance in ending (in shares)   28,500 28,500
Common Stock [Member]      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning   $ 300
Balance at beginning (in shares)     300
Original capital contribution $ 300    
Original capital contribution (in shares) 300    
Elimination of common stock of Omni Shrimp upon merger     $ (300)
Elimination of common stock of Omni Shrimp upon merger (in shares)     (300)
Capital Contribution from Reverse Merger     $ 2,612
Capital Contribution from Reverse Merger (in shares)     2,911,658
Issuance of common stock for conversion of debt     $ 943
Issuance of common stock for conversion of debt (in shares)   942,527 942,527
Balance at ending $ 300 $ 3,854 $ 3,854
Balance in ending (in shares) 300 3,854,185 3,854,185
Dividends on Preferred stock Series E [Member]      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning  
Issuance of Dividends on Preferred stock Series E     (26,099)
Balance at ending $ (26,099) (26,099)
Additional Paid-in Capital [Member]      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning   977
Original capital contribution 977    
Elimination of common stock of Omni Shrimp upon merger     300
Capital Contribution from Reverse Merger     (2,941)
Issuance of common stock for conversion of debt     16,527
Balance at ending 977 14,864 14,864
Accumulated Deficit [Member]      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Balance at beginning   (1,277)
Net loss (1,277)   (3,433,057)
Balance at ending (1,277) $ (3,434,334) (3,434,334)
Balance at beginning   0
Original capital contribution 1,277    
Issuance of common stock for conversion of debt     17,470
Issuance of common stock for conversion of debt (in shares)   1,948,977  
Issuance of Dividends on Preferred stock Series E     (26,099)
Net loss (1,277)   (3,433,057)
Balance at ending $ 0 $ (3,441,687) $ (3,441,687)